Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial (Q38980584)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial |
scientific article |
Statements
1 reference
Initial therapy with nucleoside reverse transcriptase inhibitor-containing regimens is more effective than with regimens that spare them with no difference in short-term fat distribution: Hippocampe-ANRS 121 Trial (English)
1 reference
1 reference
Gilles Peytavin
1 reference
Jean-Michel Molina
1 reference
Claudine Duvivier
1 reference
Jade Ghosn
1 reference
Lambert Assoumou
1 reference
Cathia Soulié
1 reference
Vincent Calvez
1 reference
Michèle Algarté Génin
1 reference
Olivier Bouchaud
1 reference
ANRS 121 study group
1 reference
18 July 2008
1 reference
1 reference
62
1 reference
4
1 reference
797-808
1 reference
Identifiers
1 reference
1 reference